Medical Device Leaders Debate on the Future of Combination Products at PFS San Diego Summit

Press Release ( - SAN DIEGO - Apr 27, 2017 - SMi Group will welcome the expertise of their growing Pre-Filled Syringes community this June as they invite attendees to share their thoughts at the 2nd annual North American West Coast summit on Pre-Filled Syringes, set to take place on June 5th and 6th in San Diego, California.

Entitled “Combination Products – Challenges and Opportunities”, the first interactive panel debate will take place at the end of day one and will be led by Allergan, MedImmune, Ferring and Eli Lilly. Highlights will include talks surrounding patient centricity, manufacturing guidelines and hurdles in obtaining regulatory approval for pre-filled syringes and pens in human factor studies.

The second debate will take place at the end of day two and will be led by Regeneron and Worrell. With a focus on “The Future of Parenteral Drug Delivery,” attendees will address challenges of high volume injectable’s from a commercial, user and technological point of view. Progressive insight will also be given on the next generation of PFS products including connected devices, wearable injectors and hand held auto injectors.

Some of those confirmed to attend include: Aerpio Therapeutics | Allergan | Amgen | BMS | Catalent Pharma Solutions | Eli Lilly | Fresenius Kabi USA | Genentech | Insulet Corporation | Ionis Pharmaceuticals, Inc. | ISPG, Inc. | MedImmune | Mitsubishi Gas Chemical America Inc | Nemera | Nipro Europe NV | Novo Nordisk A/S | Regeneron Pharmaceuticals Inc | Roche Diagnostics  | Smithers Rapra | Smiths Medical | Sterilzation Validation & Consulting | Terumo Europe | West Pharmaceutical Services, Inc. | Worrell | Xeris Pharmaceuticals | Zeon Chemicals L.P.

Further details including a detailed conference agenda and speaker line-up are available at…

Pre-Filled Syringes West Coast takes place on June 5th and 6th 2017 at the Hyatt Regency, San Diego, CA


Contact Information:

For all media inquiries contact Teri Arri on Tel: +44 (0)20 7827 6162 / Email:

Source : SMi Group

You may also like this  



Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Or form here

Already have an account ? Login

Reset Password

Already have an account ? Login


If you have any concerns regarding this press release, please contact the Author / Media Contact / Business of this press release. ePRNews is not resposible for the accuracy of the news posted and do not endorse, support any product/ services/ business mentioned and hereby disclaims any content contained in this press release.